...
首页> 外文期刊>Journal of affective disorders >Predicting response to cognitive therapy and interpersonal therapy, with or without antidepressant medication, for major depression: A pragmatic trial in routine practice
【24h】

Predicting response to cognitive therapy and interpersonal therapy, with or without antidepressant medication, for major depression: A pragmatic trial in routine practice

机译:预测重度抑郁症对认知疗法和人际关系疗法的反应(含或不含抗抑郁药):常规实践中的一项实用试验

获取原文
获取原文并翻译 | 示例

摘要

Background: Identifying patient characteristics that predict response within treatments (prognostic) or between treatments (prescriptive) can inform clinical decision-making. In this study, we sought to identify predictors of response to evidence-based treatments in a sample of depressed patients seeking help in routine practice.Methods: Data come from a pragmatic trial of 174 patients with major depression who received an evidence-based treatment of their own choice: cognitive therapy (CT), interpersonal therapy (IPT), antidepressant medication (ADM) alone or in combination with either of the two psychotherapies. Patient characteristics measured at baseline were examined to see if they predicted subsequent response as measured with the Beck Depression Inventory (BDI) over the course of 26 weeks of treatment, using mixed regression modeling.Results: Higher agoraphobia scores at baseline predicted more change in depression scores across treatments, irrespective of the treatment received. Physical functioning moderated the response to treatment: patients with high physical functioning fared better in combined treatment than patients with low physical functioning, whereas physical functioning did not predict a differential response in the psychotherapy group. Moreover, the lowest levels of physical functioning predicted an increase of depressive symptoms in combined treatment.Limitations: A relatively small sample size, and selection of several predictors that were less theory-driven, which hampers the translation to clinical practice.Conclusions: If replicated, the prognostic and prescriptive indices identified in this study could guide decision-making in routine practice. Development of more uniform requirements for the analysis and reporting of prediction studies is recommended.
机译:背景:确定可预测治疗内(预后)或治疗间(规定)反应的患者特征可为临床决策提供依据。在这项研究中,我们试图在寻求常规实践帮助的抑郁症患者样本中确定对循证治疗反应的预测因素。方法:数据来自对174名重度抑郁症患者进行了循证治疗的证据他们自己的选择:认知疗法(CT),人际疗法(IPT),单独的抗抑郁药(ADM)或与两种心理疗法结合使用。使用混合回归模型检查了基线时测量的患者特征,以观察他们是否预测了贝克抑郁量表(BDI)在治疗26周期间的后续反应。结果:基线时较高的广场恐惧症评分预示了抑郁症的变化不论接受何种治疗,所有治疗的得分。身体机能减轻了对治疗的反应:身体机能高的患者在综合治疗中的表现要好于身体机能低的患者,而身体机能在心理治疗组中并未预测出差异反应。此外,最低的身体机能水平预示着联合治疗中抑郁症状的增加。局限性:样本量相对较小,并且选择了一些不受理论驱动的预测因子,这阻碍了将其转化为临床实践。 ,这项研究中确定的预后和规范性指标可以指导常规实践中的决策。建议为预测研究的分析和报告制定更统一的要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号